Track topics on Twitter Track topics that are important to you
The biotech is facing the financial music after clinical spending has left its coffers worryingly bare, and is looking at strategic alternatives following Nasdaq's stern words.
Original Article: Share price dip leaves MabVax fighting to find its feetNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...